½@¤ß¬O¡y¦Û³¬¯gı¿ôºô¯¸¡zªº³Ð¿ë¤H©M¥D½s¡C¦o¤£¶È¬O¤@¦ì¦Û³¬¨àªº¥À¿Ë¡A¨Ã¾Ö¦³³Â¦{¤j¾Ç®¿«Âº¸¤À®Õ( U of Massachusetts at Lowell)ªº¦Û³¬¯g¦æ¬°¤z¹wªººÓ¤hµý®Ñ¡C¦Û2007¦~¡A¦o©Ò«Ø¥ßªº¡y¦Û³¬¯gı¿ôºô¯¸¡z¡A¸Ô²Ó¥Z¸ü¬ü°ê³Ì·sªº¦Û³¬¯gÂå¾Ç¬ã¨s³ø§i¡B¥\¯à¦æ¬°¤ÀªR(FBA)¡B¥¿²Îªº Home-Based ®¿º¿´µ(Lovvas)À³¥Î¦æ¬°¤z¹w±Ð¾Ç(DTT)¡B«e¦]±±¨î¤¶¤J (Antecedent Control Intervention) ¦Ü¹ê»Úªº¦æ¬°¤ä´© (PBS)¡B¨¥»y±Ð¾Ç (Verbal Behavior)©M¤£¦PµØ¤H®a®xªº¦Û³¬¯g¤ß¸ô¾úµ{¡C

 

¦oªº±Ð¾ÉµÛ­«¬¡¥ÎÀ³¥Î¦æ¬°¤ÀªR(ABA) ªº¬ì¾Ç¡ADTT ªºªºÂ÷ªR­ì«h©M Differential Reinforcements¡B»P¨¥»y¦æ¬°(VB) ¹B¥Îªº¾ã¦X¡A±N¦Û³¬¯g±Ð¨|¥Í¬¡¤Æ¡F¨Ã´£¨Ñµû¦ôªº¤èªk¡A«ö·Ó«Ä¤l¤£¦Pªº¦¨ªø¶¥¬q¦Ó³]­p¤£¦Pªº±Ð¾Ç¤º®e¡B¹ªÀy¼W±j«Ä¤lªº¿W¥ß¾Ç²ß¦æ¬°¡A©M¦p¦óÆ[¹î¦Û³¬¨àªº¦æ¬°°Ê¾÷ (FBA)¡A¥H´£¨Ñ²Å¦XªÀ¥æ´Á«Ýªº´À¥N¦æ¬° (PBS)¡AÄ~¦Ó´î®z­t­±ªº°ÝÃD¦æ¬°¡A¬°­n§ïµ½¦Û³¬¨àªºªÀ·|¥Í¦s©M¿W¥ßªº¥\¯à¡C

 

¡y¦Û³¬¯gı¿ôºô¯¸¡z¡A³Ì­«­nªº¬O­n±a¥X¡uı¿ô¡vªº©I¥l¡CÂǵ۶}³]ªÀ°Ïªº±MÃDÁ¿®y¡AÀ°§U¤÷¥ÀÁA¸Ñ¨ì¦Û³¬¯g¤£¬O©G¶A¡A¨Ã¨ó§U¤÷¥À¦P¤ßªº­±¹ï¦Û³¬¯g¡A¦P®É»²¾É¤Ò©d«O¦u¦b¦Û³¬¯g¬D¾Ô¤¤ªº¯«¸t±B¬ù¡F¨Ã¦bºô¤W¼½¥Xµø°Tªº¼v­µ±Ð¾É¡A³ê¿ô¤H­Ì­«·s»{ÃѵL±ø¥óªº·R¡C

¡ãActs 3:16

Sing Hallelujah¡I

Grace wins every time¡I

 

 

³]¬°­º­¶
¥[¤J¡u§Úªº³Ì·R¡v
ÂsÄý¬y¶q²Î­p
¤H¼Æ: 13,771,465 
­¶¼Æ: 23,712,561 
¤U¸ü: 10,211 
Since May 2007

  
   

Bookmark and Share   
 
§Q§¿¾¯ªvÀø¦Û³¬¯g-2017¦~ªº§ó·sµo²{

½@¤ß
4/13/2017



ÃöÁä¦r¡G¥¬¬ü¥L¥§(Bumetanide)
¤¤¤å别¦W¡G¥¬¬ü¥L¥§¡B«K¦h¡B¤BÓi³t§¿¡B¤B­f®ñ»Ä¡B¤B§¿Ói
­^¤å别¦W¡G Aquazone¡BBonures¡BBumex¡BBurine¡BButinat¡BCambiex¡BDiurama¡BFontego¡BFordiuran¡BLunetoron¡BSegurex
ÃÄ«~Ãþ别¡G §Q§¿¾¯

±q2012¦~¦Ü¤µ¡ANeurochlore¡A¦Û³¬¯g©M¨ä¥Lµo¨|»Ùꪺ·sÀøªk¥Íª«§Þ³N¤½¥qªº¬ì¾Ç®a¡A°w¹ï§Q§¿¾¯(Bumetanide)ªvÀø¥i§ïµ½¦Û³¬¯g(ASD) ªº®Ö¤ß¯gª¬¡A¥]¬AªÀ¥æ»Ùê©M©T°õ­«ÂЪº¨èªO¦æ¬°¡AÄ~Äò¶i¦æ«ÈÆ[ªº¹êµý¬ã¨s¡C

³Ì·s½Æ»s§Q§¿¾¯(Bumetanide)ªvÀø¦Û³¬¯gªºÁ{§É¬ã¨s¥Z¸ü¦b¡mNature¡n2017¦~3¤ë14¤é½u¤WªºTranslational Psychiatry (µ§Ä¶ºë¯«¯f¾Ç) ¤W¡A½ÐÂIÀ»³sµ²¥H¶i¤J­ì¤åµoªí¡G
http://www.nature.com/tp/journal/v7/n3/full/tp201710a.html

¬ã¨s¤H­û¦b¸Ó¶µ¹êÅç³ø§i¤¤«ü¥X¡A¡uBumetanide was effective in improving ASD-related symptoms across the pediatric age range, as assessed by the Childhood Autism Rating Scale (CARS), the Clinical Global Impression Improvement scale (CGI-I), and the Social Responsive Scale (SRS)¡v
ÂǥѦ۳¬¯g¨àµ£µû©w¶qªí(CARS) ¡Aºî¦XªºÁ{§É·N¨£§ïµ½¶qªí (CGI-I)¡A©MªÀ¥æ¦^À³¶qªí (SRS) ¡A§Q§¿¾¯(Bumetanide) ªvÀø¦³®Ä¦a§ïµ½¤p¨à¦~ÄÖªºASD ¬ÛÃöªº¯gª¬µ{«×¡C

¸Ó¶µ¬ã¨s½×¤åªº­º®u¬ã¨s­û¯Ç¥»ªü¨½³Õ¤h(Yehezkel Ben-Ari, PhD)¡A¤]¬O¤@®a±Mª`¤_ªvÀøµo¨|»ÙꪺÀç§Q¤½¥qNeurochloreªºÁ`µô¡A¨äÁ`³¡³]¦bªk°ê°¨ÁÉ¡C

­º®u¬ã¨s­û¯Ç¥»ªü¨½³Õ¤h¦b2012¦~ªº¬ã¨s¡A´£¨Ñ¼Æ¾Úªº¼Ë¥»¬O60¦ì(3¦Ü11·³)¦³¦Û³¬¯g©Î¨È´µ§B®æ¶EÂ_ªº¨àµ£¡A¬°´Á 3 ­Ó¤ë¨C¤Ñ1²@§J(mg)§Q§¿¾¯(Bumetanide)¡A¦³¥|¤À¤§¤TÄY­«©Ê¦Û³¬¯gªº«Ä¤l­Ìªí²{¯gª¬´î»´¡F¦ý¤£¥X©Ò®Æªº°Æ§@¥Î¤]µLªkÁ×§Kªº²£¥Í¡A«Ä¤l­Ì¤]³QÆ[¹î¨ì§C¹[¦å¯g¡A»Ý­n¹[¸É¥R¾¯ªºªvÀø¡C­ì¤åÄm¸ê®Æ½ÐÂIÀ»¤U­±¡G
http://www.nature.com/tp/journal/v2/n12/full/tp2012124a.html

2017¦~ªº¬ã¨s¼Æ¾Úªº¼Ë¥»¬O88¦ìASD±wªÌ¡A¦~ÄÖ¾î¸ó2¦Ü18 ·³¡A 78¦ì¬O¨k«Ä¡A10¦ì¬O¤k«Ä¡A²Ó¤À¥|­Ó¦~ÄÖ²Õ©MÀH¾÷±µ¨ü§Q§¿¾¯(Bumetanide) 0.5¡B 1.0 ©Î 2.0 ²@§J(mg)¨C¤é¨â¦¸¡B©Î¦w¼¢¾¯¡A¹êÅç¶i¦æ¹Lµ{ 3 ­Ó¤ë¡C

¦³13­Ó¯f¤H¦bªA¥Î§Q§¿¾¯(Bumetanide) ªºªvÀø²Õ¦]¤£¨}¤ÏÀ³©Î¨ä¥L­ì¦]¡A¦b¬ã¨sµ²§ô¤§«e°h¥X¡C¦b³o13¦ì±wªÌ¤¤¡A4­Ó¦³¤¤«×ªº§C¹[¦å¯g¡B 5­Ó¦³»P¦h§¿¬ÛÃöªº¤£¨}¤ÏÀ³¡B ¨â­Ó¤H¦³§xÃø¿í¦u¬ã¨s¨ó©w¡B ¤@­Ó¤H¥¢¥h联µ¸¡A©M¤@­Ó¬O¦³¿ù»~ªº¶EÂ_¡C

¦b¦w¼¢¾¯²Õ¤¤¡A¤@¦ì¯f¤H°±¤î¿í¦u¦w¼¢¾¯¬ã¨sªº¨ó©w¡A¦³¤@¦ì¬O­nªA¥Îºë¯«ÃĪ«¦A¥[¤W¦w¼¢¾¯ªº¨Ï¥Î¦³§xÃø¡C¦]¦¹¡A­ì¥ý 88 ¦ì¼Ë¥»¥u¦³73¦ì±wªÌ§¹¦¨¸ÕÅç¡F¤À§O²Ó¤À¦¨20¦ì¡B 19¦ì ©M 13 ¦ì±wªÌ¡AªA¥Î 0.5mg¡B1.0mg¡B©M 2.0 mgªº¤T­Ó¤£¦P¶q§Q§¿¾¯(Bumetanide)ªº¤p²Õ¡A¦A¥[¤W¦w¼¢¾¯²Õ¦³21¦ì±wªÌ)¡C

©Ò¦³ªvÀø²Õªº±wªÌ®Ú¾Ú¼Ú¬wÂå¾Ç¾÷ºcªº¥­§¡¼Æ(the mean)¡A¨Ï¥Î¦Û³¬¯g¨àµ£µû©w¶qªí(CARS) ªº¤À¼Æ¬O¤j©ó 34 ¡A¬O°ª©óÄY­«¦Û³¬¯gªº±o¤À¡C

§¹¦¨³o¶µ¹êÅ窺¦Û³¬¯g±wªÌ¨º¨Ç¯f¤H¡A¦Û³¬¯g¨àµ£µû©w¶qªí(CARS) ªº¥­§¡­È¡A±q¹êÅç¶}©l«eªº°ò½u¦b3 ­Ó¤ë´Á¶¡«ùÄò¤U­°¡F©Ò¦³ªvÀø²Õ¤§¶¡ªº®t²§¥Î²Î­p¾Ç·N¸q»¡©ú (P =.015)©úÅã³Ì¤j¥­§¡ÅܤƬO§Q§¿¾¯(¥¬¬ü¥L¥§) 2.0 ²@§J²Õ (-5.35) ¡B©M³Ì¤pÅܤƪº¬O¦w¼¢¾¯²Õ (-1.79; ¦¨¹ï¤ñ¸û P =.017 )

23¦ì¨Ï¥Î§Q§¿¾¯(¥¬¬ü¥L¥§)ªvÀøªº±wªÌ¡A¦Û³¬¯g¨àµ£µû©w¶qªí(CARS) ªº¥­§¡­ÈÅã¥Ü¡A±q°ò½u¨ì 3 ­Ó¤ë¬Û¤ñ´î¤Ö¶W¹L6 ÂI¡C

¬ã¨s­ûªº¼Æ¾Ú«ü¥X§Q§¿¾¯(¥¬¬ü¥L¥§)ªvÀø¡A©úÅ㪺¶i¨B¬Oªí²{¦bºî¦XªºÁ{§É·N¨£§ïµ½¶qªí(CGI-I) ¡A 90 ¤Ñªº¤À¼Æ(P =.004) ¡B©MªÀ¥æ¦^À³¶qªí (SRS) ªºµû¤À¶W¹L 10 ­Ó¦Ê¤ÀÂI (P =.020 )¡C

¦ý¬O¤÷¥À»Ý­nĵıÅU¼{ªº¡A¬O§Q§¿¾¯(¥¬¬ü¥L¥§)ªvÀø¤£¨}¤SÀWÁcªº°Æ§@¥Î¡A¦b©ó§C¹[¦å¯g¡BÀW§¿¡B­¹±ý¤£®¶¡B ²æ¤ô¡A©Mµê®z¡C¤×¨ä§C¹[¦å¯g¥D­n·|µo¥Í¦b 1.0 ©M 2.0 ²@§J¨C¤Ñ¨â¦¸¾¯¶qªºªvÀøªì´Á¡A»Ý­n¨Ï¥Î¤fµÄ¹[¸É¥R¾¯³v¨B§ïµ½¡C¤£¨}¤ÏÀ³ªºµo¥Í²v¬Ò¬O»P¥¬¬ü¥L¥§ªº¾¯¶q©M¨Ï¥ÎÀW²v¦³ª½±µªº¬ÛÃö©Ê¡C

§Q§¿¾¯(¥¬¬ü¥L¥§)³oºØÃĪ«ªº¦³§Q®Ä¯q­·ÀI²v¬O¦b 1.0 ¾¯¶q¨C¤é¨â¦¸¡C³o­Ó±À½×©|»Ý­n¦b¥¼¨Óªº²Ä¤T¶¥¬q¬ã¨s¤¤³Q´ú¸Õ¡C

¥Ø«e§Q§¿¾¯(¥¬¬ü¥L¥§)³oºØÃĪ«ªº¸ÕÅç§½­­©Ê¡A¦b©ó¬ã¨sªº¼Ë¥»¤Ó¤p©M·¥µuªº3­Ó¤ëÆ[¹î´Á¡C©Ò¥HµLªk§ó·Ç½T¹w´úªvÀøªº¨ä¥L¤ÏÀ³©M°Æ§@¥Î¡A¦p´¼°Óªº¼vÅT¡B¦b®Õªº¦æ¬°¡B©M¤£¨}ªº¦X¨Ö¯g¡CÁÙ¦³·¥ºÝªº²§½è©Ê¦Û³¬¯g¦b¤µ«áªºÁ{§É¸ÕÅç±N¯Ç¤Jµû¦ôªºµ²½×¡C

³Ì«á¡A§Q§¿¾¯(¥¬¬ü¥L¥§)ªºÀW§¿¦æ¬°·|¼vÅT¹êÅ窺³æª¼¹Lµ{¡C

§Q§¿¾¯(¥¬¬ü¥L¥§) ªºÃĪ«¹êÅç¬ã¨s¬O¥Ñ Neurochlore¡A¦Û³¬¯g©M¨ä¥Lµo¨|»Ùꪺ·sÀøªk¥Íª«§Þ³N¤½¥qÃÙ§Uªº¡C­º®u¬ã¨s­û¯Ç¥»ªü¨½³Õ¤h( Dr Ben-Ari)©M¥t¨â­Ó¬ã¨s¦X§@ªÌ¬ONeurochlore¤½¥qªº³Ð©l¤H©MªÑªF¡F³o¬O§Q§¿¾¯ªvÀø¦Û³¬¯g¬ã¨s¤£®e­~Áתº§Q¯qµJÂI¡C

ºI¨ú¥»¤å³¡¥÷内®e©Î¤Þ¥Î¡A½Ðµù©ú·½¤_¦Û³¬¯gı¿ôºô¯¸¡C


¬ÛÃö°T®§
MMR-¤T¦X¤@¬Ì­]»P¦Û³¬¯gªº³sµ²¡Ð¬ü°êÂå¾Ç¨ó·| (JAMA)
¦³¥v¥H¨Ó³W¼Ò³Ì¤jªº¦Û³¬¯g°ò¦]²Õ¬ã¨sµo²{¡G ¦Û³¬¯g­Y¦
¨C5­Ó¨àµ£¦­´Á¶EÂ_¬Oª`·N¤O¯Ê³´ ¡A ¦³2­Ó¤S³Q¶EÂ_¥X±w
¬ÛÃö°T®§

DSM5¦Û³¬¯gÀWÃÐ(ASD)¡B¦n°Ê¯g(ADHD) »P·s¶µ¥ØªÀ¥æ[°È¹ê]·¾³q»Ùꪺ¶EÂ_¼Ð·Ç²Ó¥Ø 
§Úªº«Ä¤l¦³¦Û³¬¯g¡A¦n°Ê¯g¡BªÀ¥æ·¾³q»Ùê¬O¥²µM­Ý¦³ªº¶EÂ_¶Ü¡H

¶W¶Vªí­±ªº¶¼­¹°ÝÃD¡A1999-2014¦~¬ì¬ã±´°Q¦Û³¬¯g¨àµ£ªº­G¸z¹D¯gª¬©MªÎ­D¯g 
¬Ý¤£¨£°ÝÃD¬O³Ì¤jªº°ÝÃD¡I

2018¦~¤@¶µ­º¦¸¦b¥þ¬ü°ê¶i¦æªvÀø¦Û³¬¯gªº·sÃÄ´ú¸Õ±M®× 
Balovaptan(RG7314), 2018¦~1¤ëÀò±o¤F¬ü°ê­¹«~©MÃĪ«ºÞ²z§½(FDA) ±Â¤©ªvÀø¦Û³¬¯g(ASD)ªº¡u¬ð¯}©ÊÃĪ«¸ê®æ»{©w¡v

¦Û³¬¯g¨àµ£ºÎ¯v°ÝÃDªº¬ã¨s±M®×©M¨ó§U«ØÄ³ 
¦h¹F80% ªº¦Û³¬¯g¨àµ£¦³¬YºØµ{«×ªººÎ¯v§xÃø¡I

¦Û³¬¯g¼Ò«¬¹êÅ繫¥i¥H®M¥Î¦b¤HÃþªº¦Û³¬¯g±wªÌ¨­¤W¶Ü? 
·Q±q¦Ñ¹«¨­¤W±o¨ì¦Û³¬¯gªÀ¥æ»Ùꪺµ²½×, ¥L­Ì¥i¯à»Ý­n¦^¨ì°ò¦¥h¦³±ø¤£¯¿¦a½s¦C¦Ñ¹«©Ò¦³ªº¦æ¬°¡Cby Valerie Bolivar PhD

¦Ñ¹«ªº¬ã¨sªí©ú¥¥´Áªº·P¬V¼vÅTÀ¦¨àªº¯«¸gµo¨|,¥]¬A¦Û³¬¯g¡C 



¯}¤Ñ¯î·Ç½T¦a¹w´úÀ¦¨à¦³¦Û³¬¯gªº³Ì·s¤èªk 
¸Óºtºâªk³Ì²×¥¿½T¹w´ú¦Û³¬¯g¶EÂ_ªº¨àµ£¡A
¹F¨ì
81% ªººë½T«×©M 88%ªºÆF±Ó©Ê¡C


¸gÆ`ºÏ¨ë¿E§Þ³N(TMS)¦b¦Û³¬¯gªº¬ì¬ãÀ³¥Î 
¥Ø«e,TMSªºÁ{§É¸ÕÅçÁÙ¦b¶i¦æ,
¥D­n¬O°w¹ï¦¨¦~©ÎªÌ«C¤Ö¦~¦Û³¬¯gÃШt±wªÌ¡C
¦ý¬O
,TMSªºµ²ªG³£¬Oªì¯Åªºµ²½×¡C


§Q§¿¾¯ªvÀø¦Û³¬¯g-2017¦~ªº§ó·sµo²{ 
ÂǥѦ۳¬¯g¨àµ£µû©w¶qªí(CARS) ¡A
ºî¦XªºÁ{§É·N¨£§ïµ½¶qªí (CGI-I)¡A
©MªÀ¥æ¦^À³¶qªí (SRS) ¡A
§Q§¿¾¯(Bumetanide) ªvÀø¦³®Ä¦a§ïµ½
¤p¨à¦~ÄÖªºASD ¬ÛÃöªº¯gª¬µ{«×¡C


2012-2014 ¥ª¥kºD¥Î¤âªº°ê»Ú¬ì¬ã¸ê®Æ -´L­«¦Û³¬¯g¨àµ£¨Ï¥Î¥ª¤âªº¤¤¼Ï¯«¸g¨t²Î°¼ªº¤Ï®g 
¥ª¤â¡H¥k¤â¡H¥k¸£¡H¥ª¸£¡H

¤£­n»´©ö¬Û«H¨Ó¦Û±M·~¨ø³dªºÁÀ¨¥¡G¦Û³¬¯g¨àµ£¤£À´¬O¦]¾Ç²ß¿ð½w¡I 

¤÷¥Àªü¡A¬°¤F§A¦Û¤vÁÙ¦³«Ä¤l¤@¥Íªº¦n³B¡A§A¤£¥i¤£ª¾¡B¤]¤£¥iµLª¾¥¿½Tªº¬ì¾ÇÃÒ¾Ú¡G
¬ü°êªºCDC©x¤è¤_2016 ¦~¤½吿¬ì¾ÇÃÒ¾Ú¡A
¡u´X¥G46%¦Û³¬¯g«Ä¤l¦³¥­§¡©Î°ª©ó´¼°Ó85¡v¡C
¾Ç²ß¿ð½w°Z¬O¯u²z¡H


2016¦~ ¥¿½T»{ÃѦ۳¬¯gªº³Ì·s10¶µ¸ê®Æ 
¨­¬°¤÷¥À¡A
¤£¥i¤£ª¾¡A
¤£¥iµLª¾¡C



MMR-¤T¦X¤@¬Ì­]»P¦Û³¬¯gªº³sµ²¡Ð¬ü°êÂå¾Ç¨ó·| (JAMA) ´Á¥Zµoªí¤F¦³¥v¥H¨Ó³W¼Ò³Ì¤j¦Û³¬¯g»PMMRªº¬ã¨s¤ñ¸û 



¤@ºØÁôÂ꺻Ùê¡G½Í·Pı²Î¦X»Ùê©MªvÀø 



¦³¥v¥H¨Ó³W¼Ò³Ì¤jªº¦Û³¬¯g°ò¦]²Õ¬ã¨sµo²{¡G ¦Û³¬¯g­Y¦b®a®x¤¤¹B¦æ¡A±M®a·|«Ü§Ö°²³]¬O±q¥L­Ìªº¤÷¥ÀÄ~©Ó¬Û¦Pªº¦Û³¬¯g©ö·P°ò¦]¡C²{¦b¬Ý¨Ó¡A³o¬O¤£¥¿½Tªº·Qªk¡C 
³o¶µµo²{¡A¬D¾Ô¤F¿ò¶Ç²z½×ªø´Á¥H¬°¬Oªº±À©w¡C

¥»¥Ø¿ý¤¤³Ì¦h¾\Äýªº¤å³¹

¦Û³¬¨àªº­¹ª«¹L±Ó 

­È±o­«µøªº¬O,³o¨Ç«Ä¤lªº¹L±Ó¤ÏÀ³,¦b¥Ö½§ªº¥~ªí¤W¬Ý¤£¥X¨Ó!!



°£¨E¤¤¬rªº²{¦æ¤èªk 
¦pªG¦Û³¬¨à³Q´ú¥X¦³­«ª÷Äݤ¤¬r,¦b¬ü°ê³\¦hªºÂå¥Í¶}©l¨Ï¥ÎDMSA

Âå¥Í¯à¬°¦Û³¬¨à°µ¤°»ò? (1) 
¤@¦ì¹ïªºÂå¥Í¯à¦b¦Û³¬¨àªº¨­¤W¶}±Ò³\¦h©_§®ÂàÅܪº§@¬°!

ºû¥L©Rªº§U¯q 
¯S®í¨àµ£ªº¯S®í¶¼­¹!

¤°»ò¬O¦Û³¬¯g 
©Ò¦³ªº¦Û³¬¨à³£¦³¥H¤U¬Û¦Pªº¯S¼x

Copyright 2007-2018 AutismAwaking.org All Rights Reserved. Powered by W4J(Web for Jesus) Ministry